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Rovira1, Javier Buesa1, Vicente Monedero2 & Maria Carmen Collado2
Host genetic factors, such as histo-blood group antigens (HBGAs), are associated with susceptibility 
to norovirus (NoV) and rotavirus (RV) infections. Recent advances point to the gut microbiome as a 
key player necessary for a viral pathogen to cause infection. In vitro NoV attachment to host cells and 
resulting infections have been linked to interactions with certain bacterial types in the gut microbiota. 
We investigated the relationship between host genotype, gut microbiota, and viral infections. Saliva 
and fecal samples from 35 adult volunteers were analysed for secretor status genotype, the gut 
microbiota composition by 16S rRNA gene sequencing, and salivary IgA titers to NoV and RV. Higher 
levels of IgA against NoV and RV were related to secretor-positive status. No significant differences 
were found between the FUT2 genotype groups, although the multivariate analysis showed a 
significant impact of host genotype on specific viral susceptibilities in the microbiome composition. A 
specific link was found between the abundance of certain bacterial groups, such as Faecalibacterium and 
Ruminococcus spp., and lower IgA titers against NoV and RV. As a conclusion, we can state that there is 
a link between host genetics, gut microbiota, and susceptibility to viral infections in humans.
Acute gastroenteritis (AGE) is a major worldwide health issue, associated with a high economic burden in 
developed countries and high annual mortality, particularly affecting children, in developing countries1. The 
major etiological agents of viral AGE in children are rotaviruses (RVs) (90% represented by RV group A [RVA])2 
and noroviruses (NoVs)1.
It was previously shown that susceptibility to NoV infections differed between individuals3 and was asso-
ciated with histo-blood group antigens (HBGAs)4. It has been suggested that HBGAs expressed on epithelial 
surfaces function as receptors for NoV, with different NoV strains showing different properties with regard to 
the ability to bind to different HBGAs5. Non-secretor individuals (lacking both functional FUT2 alleles) do not 
express H-antigen structures (Fucα 1,2-Galβ 1,3-GlcNAcβ 1,3-Gal) on their mucosa and are less susceptible to 
NoV3. Based on the findings of recent publications6,7, the determination of susceptibility to RV infections should 
also consider HBGA phenotypes. Several studies have suggested that the non-secretor phenotype was restrictive 
to P[8] and P[4] RV genotype infections, as revealed in analyses of symptomatic infections6,8–11 or specific seral 
IgG levels12.
The gastrointestinal environment is a very complex ecosystem that contains a vast bacterial population in 
terms of numbers and diversity13. This population varies between individuals and is subject to changes depending 
on diverse factors, such as genetics, diet, and health status. Intestinal bacteria have a vast enzymatic potential for 
scavenging diet and host glycans (e.g., carbohydrate structures from O-glycosylated mucins and other HBGA 
structures on mucosal surfaces)14. Furthermore, the high L-fucose concentration in the gastrointestinal tract plays 
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an important role in the ecology of this niche, assisting in commensal colonization15,16. Intestinal microbiome 
analyses have also revealed differences in the microbiota structure based on FUT2 status, with non-secretors 
showing reduced microbial richness compared to secretors17,18.
Some intestinal viruses rely on the microbiota for infectivity. No cell-culture system had previously allowed 
the in vitro replication of human NoV until recent findings showed that the NoV GII.4 genotype can infect 
human lymphocytic B cell line if an accompanying intestinal microbiota is present19. Moreover, NoV repli-
cation has been recently achieved in human enteroids derived from stem cells20. There are also evidences for 
microbiota-dependent RV infections in a study in which the use of germ-free animals or antibiotic treatments 
resulted in a > 40% reduction of viral infections in a mouse model21.
In the present study, we analysed the link between secretor status, the gut microbiota, and susceptibility to 
RV and NoV infections in healthy individuals, measured via salivary IgA titers to RV and NoV. The expected 
link between secretor status and susceptibility to RV and NoV was found, and multivariate analyses showed that 
secretor status, the microbiota, and viral susceptibility are interdependent for both RV and NoV. Finally, specific 
correlations were found between certain bacterial groups and the risk of RV and NoV infections.
Results
Secretor status correlated with salivary anti-NoV and anti-RV titers. The aim of the present study 
was to identify relationships between viral susceptibility, host genetic factors, and the intestinal microbiota. To 
avoid invasive procedures, salivary IgA titers to NoV and RV were obtained. The proportion of non-secretor 
individuals in the studied population was 22.8%, which is in accordance with the prevalence of this phenotype 
in Caucasian populations (20%). The observed frequencies of the three genotypes (FUT2+/+(27.2%), FUT2+/− 
(50%) and FUT2−/− (22.8%) are in concordance with the Hardy-Weinberg equilibrium (p = 0.5974 for the 
deviation from the null hypothesis). The results confirmed that normalised salivary IgA titers against NoV are 
significantly higher (p < 0.05) in secretor-positive (FUT2+/+ or FUT2+/−) individuals than in non-secretor indi-
viduals (FUT2−/−) (Fig. 1A), as has been previously described based on analyses of serum IgG titers22. When nor-
malised salivary anti-RV IgA titers were analysed, no significant differences were found between the groups, but 
the same tendency with regard to NoV was observed (Fig. 1B). The antibody titers against RV and NoV presented 
a positive correlation (p < 0.01) indicating that there is a relationship in the susceptibility to both viruses (Fig. 1C)
Figure 1. Normalised specific salivary IgA against norovirus (NoV) (panel A) and against rotavirus (RV)  
(panel B) in a population of 28 secretor (9 FUT2+/+ and 19 FUT2+/−) and 7 non-secretor (FUT2−/−) individuals. 
The correlation between the IgA titers in both viruses is shown in panel C.
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Microbiome composition. A total of 2,456,381 quality-filtered 16S rDNA sequences were obtained from 
the subjects’ feces, with an average of 70,182.3 ± 37,784.2 sequences per sample. These readings were clus-
tered into 52,769 unique operational taxonomic units (OTUs), with an average of 1,500 OTUs per subject. The 
most abundant bacterial phyla were Firmicutes (76.01%), Bacteroidetes (17.27%), Actinobacteria (2.85%), and 
Verrucomicrobia (1.98%). Proteobacteria were present in less than 1%. At family level, the most predominant 
bacteria belonged to the Ruminococcaceae (35.58%), Lachnospiraceae (23.02%), Bacteroidaceae (11.36%), and 
other Clostridiales (9.66%), followed by Veillonellaceae (3.43%) and Verrucomicrobiaceae (2.00%) (Fig. 2).
No significant differences were found between the different FUT2 allele groups (FUT2+/+, FUT2+/− and 
FUT2−/−) at the phylum level (Fig. 2A). However, significantly higher levels were found in non-secretors 
(FUT2−/−) for the families Prevotellaceae and Paraprevotellaceae compared to secretors (FUT2+/+, FUT2+/−) 
(Fig. 2B,C and D). At the OTU level, we found significant differences in 16 OTUs, mostly belonging to the 
Firmicutes and Bacteroidetes phyla; these were predominantly more abundant in the non-secretors except 
for OTU Bacteroides_51792, which was more abundant in the secretors (Supplementary Figure S1). Six OTUs 
were different between the genotype groups (Supplementary Figure S2). UNIFRAC plots did not show differ-
ent clusters between secretor and non-secretor (not shown). The Adonis analysis (permutational MANOVA 
[PERMANOVA]) showed no significant differences at the OTU level between the FUT2 groups (p = 0.179).
An alpha diversity analysis was performed on the samples after rarefaction to 12,100 sequences/sample (min-
imum sampling depth). Rarefaction curves generated for the Chao1 and Shannon indexes showed no differences 
between genotype groups (Supplementary Figure S3). Predictive functional profiling (PICRUSt) showed no sig-
nificant differences between FUT2 groups and genotypes (not shown). The most predominant bacterial genes 
were related to metabolism, genetic information processing, and environmental information processing. We also 
performed LEfSe tests to detect KEGG pathways, with significantly different abundance levels in the samples, but 
we did not find significant differences between the secretor and non-secretor samples (LDA > 2, p > 0.05).
Intestinal microbiota correlates with susceptibility to RV and NoV. A multivariate canonical cor-
respondence analysis (CCA) on the observed OTUs was performed. The plot showed clearly different groups in 
the microbial compositions between the non-secretors and the secretors at the phenotype and the genotype level 
although without significant differences (Fig. 3A and B, p > 0.05).
We found that both, anti-NoV and anti-RV IgA levels, significantly explained the variations in the gut micro-
bial composition associated to FUT2 secretor status (p = 0.040 and p = 0.014, respectively) on the CCA + analysis 
(Fig. 3C), confirming the hypothesis that all three factors (secretor status, microbiota, and susceptibility to RV 
and NoV) are interdependent.
In order to seek out the relationships between specific bacterial groups and susceptibility to RV and NoV 
infections in humans, a Pearson correlation analysis was performed showing a potential link between gut 
Figure 2. Relative abundance in % of the top phyla (Panel A) and families (Panel B) in the studied population 
including 7 non-secretor individuals (FUT2−/−), 9 homozygous secretor (FUT2+/+) and 19 heterozygous 
(FUT2+/−) individuals. Significantly different taxa at family level between secretor and non-secretors (Panel C) 
and FUT2 genotypes (Panel D) are shown as bar chart (p < 0.05, ANOVA). Standard error is depicted by error 
bars. Pair-wise comparisons are done by t-test and annotated as *p < 0.05, **p < 0.01.
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microbiota composition and the susceptibility to RV and NoV infection (Fig. 4). The results showed a signifi-
cant negative correlation between susceptibility to NoV (R = − 0.377, p = 0.03) and RV infection (R = − 0.381, 
p = 0.026) infection, with the number of bacteria from the Ruminococcaceae family (Fig. 5A and B, respectively) 
indicating that individuals with a greater abundance of Ruminococcaceae bacteria might have lower suscepti-
bility to both types of viral infection. At genus level, a negative correlation between susceptibility to NoV and 
the abundance of Faecalibacterium (R = − 0.4668, p = 0.0047) was observed (Fig. 6A). This correlation was con-
firmed at the OTU level, where a negative correlation (R = − 0.464, p = 0.005) was found for NoV susceptibility 
and for the OTU F. prausnitzii_8647 (Fig. 6B). Another significant correlation was found between the OTU 
Ruminococcaceae_23936 (R = − 0.3811, p = 0.024) and susceptibility to NoV. Different results were found among 
the different bacterial groups with regard to susceptibility to RV; a positive correlation was found at the genus 
level (R = 0.5513, p = 0.0006) between Akkermansia and susceptibility to RV (Fig. 6C). This correlation was con-
firmed at the OTU level, where a positive correlation was found between Akkermansia muciniphila_2047 and 
Figure 3. Multivariate analysis plots based microbiota composition at Operational Taxonomic Units 
(OTU) level between secretors (blue) and non-secretors (red) (Panel A) and also, between FUT2 genotypes 
(FUT2+/+ = blue, FUT2+/− = grey, FUT2−/− = red) (Panel B). Canonical correspondence analysis (CCA+ )  
showing the relationship between gut microbiome composition of the FUT2 genotypes and both anti-virus 
IgA titers, anti-RV and anti-NoV respectively (Panel C). Anti-virus IgA titers significantly explain variations 
observed in the gut microbiota (p < 0.05).
Figure 4. Pearson correlations heatmap between the susceptibility to viral infection to rotavirus (RV) 
and norovirus (NoV) (measured as anti viral IgA titers) and the relative abundances of specific bacteria at 
family level. R and p-values are indicated in the table. Sequences > 1% were included in the analysis. *p < 0.05 
and ⱡp < 0.09.
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susceptibility to RV (R = 0.499, p = 0.0023) (Fig. 6D), indicating that the abundance of this bacterium correlates 
with increased susceptibility to RV infections. Other bacterial groups also correlated negatively with susceptibility 
to RV at the genus level, including Paraprevotella (R = − 0.368, p = 0.03) and Faecalibacterium (R = − 0.3319, 
p = 0.051). However, this last correlation did not reach significance. A similar level of significance was also seen 
at the OTU level, where F. prausnitzii_38832 showed a negative correlation with susceptibility to RV infec-
tion (R = − 0.321, p = 0.06). A negative correlation was found between two different Ruminococcaceae OTUs, 
Ruminococcaceae_44932 (R = − 0.3623, p = 0.032) and Ruminococcaceae_20617 (R = − 0.357, p = 0.035), and 
susceptibility to RV infections.
Discussion
Recent research findings on the involvement of intestinal bacteria in NoV and RV infections have established 
that the microbiota plays a pivotal role in viral susceptibility19,21. Interestingly, this association exists even if 
these viruses replicate in the small intestine, whereas most of the intestinal bacteria are present in the colon. 
Susceptibility to NoV and RV infections has been related to HBGA types, but individual secretor status, linked to 
the FUT2 gene, is of special relevance. The presence of anti-RV and anti-NoV antibodies can be used as indicator 
of previous infections, constituting an indirect marker of virus susceptibility. We have seen that levels of specific 
Figure 5. Pearson correlation plots at family level and the susceptibility to norovirus (NoV) (Panel A) and 
rotavirus (RV) (Panel B). The results show significantly associated correlation between the Ruminococcaceae 
family with Anti-IgA levels (p < 0.05). A scatter plot is shown plotting the abundance of the Ruminococcaceae 
family (x-axis) versus the anti-IgA titers (y-axis).
Figure 6. Pearson correlation plots at genus and OTUS levels and the susceptibility to norovirus (NoV) (Panels 
A and B) and to rotavirus (RV) (Panels C and D). The p-values computed by correlation are reported indicating 
if the specific genus or OTU is significantly associated with Anti-IgA levels (p-values are indicated in each 
graphic).
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secretory immunoglobulins (such as IgA) in the saliva relate to the secretor phenotype for NoV. This confirms 
the relevance of FUT2 in viral infectivity and indicates that, similar to humoral responses (serum IgG22), the 
secretory antibody response also serves as a marker for susceptibility. A trend-like correlation was only observed 
for RV, which may account for the higher variability of RV depending on secretor status, which is based on viral 
genotype, as has been described for P[8] and P[6] RV variants9.
NoV and RV infections depend on the gut microbiota19,21 and on secretor status, while the gut microbiota 
is also simultaneously dependent on secretor status. Previous studies reported that the non-secretor phenotype 
was associated with a lower intestinal microbial diversity17,23,24. A study also showed differences in microbiota 
between homozygote secretors (FUT2+/+) and heterozygote secretors (FUT2+/−)18. Therefore, a dose effect of 
FUT2, as has already been described for NoV attachment25, cannot be excluded. In our study, differences in the 
microbiota could be established, although in contrast to these previous studies, no difference in microbial rich-
ness between secretor and non-secretor individuals was evidenced. A trend-like difference was only reported 
at the genus level for changes in microbial communities between FUT2 genotypes in a work by Wacklin et al.17. 
Similarly, our multivariate analysis at the OTU level did not show statistically significant differences between 
FUT2 genotypes although group clusters were clearly identified. A recently published study involving a large 
population also failed in finding an association of intestinal microbial composition with blood group (ABO) or 
secretor status26. In that study, however, other factors that could determine how FUT2 status interacts with the 
intestinal microbiota have to be considered, as the studied group was composed of female tweens with and aver-
age age of 61. Therefore, differences in physiology, diet, or activity level between different age groups may lead 
to microbiome composition differences that could mask an association with FUT226. Diet has been identified as 
a major factor influencing intestinal microbial composition27. Interactions of dietary factors that depend on the 
geographic origin of the studied individuals (Spain in our case and Finland, Germany, USA and UK in the previ-
ous studies17,18,26,28 with secretor status may explain the distinct contribution of FUT2 to the composition of the 
microbiota, as found in our study. In this sense, it has been shown that differences in intestinal microbial compo-
sition between wild-type and FUT2−/− mice with humanised microbiota are eliminated when the animals follow 
a diet deficient in polysaccharides24. Similar to this diet by phenotype (FUT2) effect on the microbiota, disease 
by secretor status effects on microbial composition have been reported for intestinal inflammatory diseases (i.e. 
Crohn disease28), when comparing healthy and diseased individuals. This suggests that FUT2 status may play a 
role in shaping the intestinal microbiome in certain diet and disease contexts.
Although the number of analysed subjects in our study (35 individuals) and the previous works (3918, 2417, 
and 1828 individuals and mice with humanised microbiota from a single donor24), with the exception of the 
mentioned female tweens study26, are low, FUT2 still emerges as a genetic factor modulating the intestinal micro-
biota. Notwithstanding, in addition to the limitation of the low number of samples, our study may present other 
weaknesses. Possible bias introduced by the use of antibiotics in the period prior to the last two months before 
sampling (our selection criteria) or by the smoking or food habits of the participants, cannot be excluded, since all 
they can impact the microbiota composition. The gender of volunteers (63% women, 37% men) may also act as a 
confounder, since male and female can display differences in microbiota composition29. However, we showed that 
there were no differences in microbiota richness and composition based on gender (Supplementary Figure S4). In 
addition, RV causes diarrhoea mostly in the young and in the present study only adults (average age of 38) were 
enrolled. Adults can also be infected by RV without symptoms, but studies with larger populations of infants, 
especially prospective studies with large cohorts are needed to obtain more robust results. Specifically, it will be 
necessary to establish the host-microbiota-viral susceptibility/protection relationship in the RV disease suscep-
tible population (< 5 years).
In spite of the exposed limitations, the inclusion of anti-NoV and anti-RV IgA levels in our analyses signif-
icantly explained the inter-individual variations in the gut microbial composition associated with FUT2 status 
(Fig. 3C). This susceptibility by phenotype effect on the microbiota reinforces the idea that the three factors are 
interconnected. Also, remarkable similarities were found between our study and previous works. In agreement 
with former reports, we identified specific microbiota associations according to secretor status. In the present 
study, members of Prevotellaceae were detected in greater numbers in non-secretors, and Prevotella OTUs and 
the Prevotella group have been previously associated with the non-secretor phenotype by 16S rDNA sequencing28 
and FISH23, respectively. Similar to our results, members of the genus Bacteroides and the family Lachnospiraceae 
were more abundant in non-secretor mice with humanised microbiota24, and increased numbers of Bacteroidetes 
have also been linked to non-secretors in two human studies18,28. However, two Bacteroides species (B. plebeius 
and B. fragilis) were related to the secretor phenotype on a PCR-DGGE analysis17. These species are characterised 
as having relatively high numbers of enzymes (i.e. α -L-fucosidases and other glycosyl hydrolases30), so they can 
take nutritional advantage of the degradation of HBGA glycan structures. Two different factors may be involved 
in the modulation of the microbiota by the availability of fucosylated carbohydrates: (i) L-fucose can be used as a 
carbon source in some intestinal bacteria, promoting their growth, and (ii) fucosylated HBGAs can act as specific 
bacterial binding sites that promote attachment and persistence in the gut. These two factors may have a complex 
relationship, as carbohydrate cross-feeding is common in the intestine, where some bacteria may benefit from the 
degradation of HBGA-glycan structures by other members of the microbiota31. Furthermore, it has been estab-
lished that the intestinal microbiota itself affects host intestinal glycosylation patterns32,33, including fucosylation.
Of note, we were able to establish correlations between different taxa and susceptibility to both NoV and RV 
(i.e., Ruminococcaceae). NoV and RV infectivity was negatively correlated with different OTUs of Faecalibacterium 
and Ruminococcaceae. Conversely, Akkermansia levels correlated to higher levels of anti-RV IgAs. The only spe-
cies of this genus, A. muciniphila, possesses a remarkable capacity for feeding on host mucins34, and trends toward 
a lower relative abundance in non-secretors17. Our data showed that Akkermansia was not different between the 
FUT2 groups, but was more abundantly present in non-secretors compared to secretors (1.08% vs 0.95%, respec-
tively). In this context, the intriguing lack of efficacy of RV oral vaccines (consisting of live-attenuated viruses) 
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in low- versus high-income countries may be based on differences between the settings that impact the intestinal 
microbiota35. However, the role of different bacterial taxa in RV/NoV infectivity still remains elusive, and estab-
lishing causal effects is still not possible. In investigations on human NoV infections of B cells, Jones et al. showed 
that Enterobacter cloacae expressed H-type substances on their surface that promoted viral binding to target cells 
and allowed in vitro infectivity19, while Miura et al. identified HBGA-like substances from Enterobacter spp. that 
promote cellular attachment of NoV viral-like particles36. In contrast, recent results with a gnotobiotic pig model 
questioned the role of this bacterium, demonstrating that E. cloacae-colonised pigs antagonised human NoV 
(GII.4) infections, resulting in reduced viral shedding37.
Understanding the interactions between virus, host, and microbiota could open new avenues in personalised 
medicine. Many possibilities exist in this context, including the rational design of NoV or RV vaccine composi-
tions/protocols based on specific interactions between viral strains/bacteria and the host genotype, or the imple-
mentation of dietary strategies (e.g., pre- or probiotics) that target specific bacterial groups, resulting in enhanced 
defences. In this regard, recent results have shown that the anti-NoV effect of vitamin A supplementation can be 
partly explained through microbiota modulation, which results in an increased number of Lactobacillus, leading 
to immunomodulatory effects mediated by IFN-β 38. Altogether, the findings show that viral infectivity must be 
understood within a holistic framework, in which host genetic background, glycobiology, and gut microbiota 
cannot be separated from viruses and host cells.
Methods
Subjects and Sampling. A total of 35 Spanish volunteers with a mean age of 38.43 ± 9.14 years and normal 
weight (body mass index [BMI] = 23.59 ± 3.68 kg/m2) participated in this study (Table 1). No gastrointestinal 
disorders, use of medicines (including probiotics and antibiotics) in the last two months, or any other diseases 
or problems were reported by the participants, who were given oral and written instructions for the standardised 
collection of samples. Stool samples were collected and kept frozen at − 20 °C until delivery to the laboratory. 
Saliva samples were collected in the morning (8–10 a.m.) to minimize the effects of the circadian rhythm. The 
participants were instructed not to smoke, eat, drink, or brush their teeth for 2 h before the saliva collection.
Ethic statement. Written informed consent was obtained from all participants, and the study protocol was 
approved by the local ethics committee of the Atencion Primaria-Generalitat Valenciana (CEIC-APCV). We con-
firm that all methods were performed in accordance with the relevant guidelines and regulations.
FUT2 genotyping. Host DNA was extracted from saliva samples using the JETQUICK Blood & cell culture 
DNA spin kit (Genomed) following the manufacturer instructions. The secretor status was investigated by geno-
typing the FUT2 gene by PCR-RFLP as described previously25.
Determination of anti-RV and anti-NoV titers in saliva samples. To determine salivary IgA titers 
to RV and NoV, microtiter plates were coated either with purified RV triple layered particles (TLPs)39 (2 μ g/ml) 
from human Wa strain (G1P[8]) or with a mix of norovirus P particles from genotypes GI.1, GII.4 (VA386_1996 
and Den Haag_2006b variants) and GII.9 produced as previously described40,41 at 1 μ g/ml each, in carbonate/
bicarbonate buffer (pH 9.6) and incubated at 4 °C overnight. Negative controls wells were coated with BSA at 1 μ g/
ml in carbonate/bicarbonate buffer. Plates were washed three times with PBS containing 0.1% Tween 20 (PBS-T) 
and blocked for 1 h at 37 °C with PBS-T with 3% BSA. After blocking, plates were incubated in triplicate with 
saliva samples at a 1:100 dilution in PBS-T with 1% BSA for 1.5 h at 37 °C and NoV- and RV-specific IgAs were 
detected with a secondary anti-human IgA antibody conjugated with HRP (Sigma) at a 1:4,000 dilution in PBS-T 
with 1% BSA for 1 h at 37 °C. Wells were washed four times with PBS-T, and the bound antibody was detected 
by the addition of 50 μ l of o-phenylenediamine (Sigma). The reaction was stopped at 10 min with 3 M H2SO4, 
and the absorbance was read at 492 nm (Multiskan FC spectrophotometer, Thermo Scientific). Microtiter plates 
were simultaneously coated with a 1:1,000 dilution of saliva in carbonate/bicarbonate buffer and processed in the 
same way as above to obtain the total IgA content of each saliva sample. The OD492 of the negative controls (BSA) 
were subtracted to obtain the specific anti-RV or anti-NoV titer. The OD492 of the specific anti-RV or anti-NoV 
was divided by the OD492 of total IgA and multiplied by 100 to obtain the normalised specific salivary IgA titer 
for each virus. All measurements were taken within the lineal range of the instrument (OD492 from 0.05 to 1.5).
Fecal DNA extraction and 16S rDNA sequencing. Total DNA was isolated from the fecal pellets 
by using the MasterPure Complete DNA & RNA Purification Kit (Epicentre) according to the manufacturer’s 
instructions with some modifications, including a bead-beater step and enzyme incubation to increase DNA 
extraction. The specific DNA extraction protocol was described previously42. DNA concentration in samples 
was measured using a Qubit® 2.0 Fluorometer (Life Technology, Carlsbad, CA, USA) and diluted to 5 ng/μ L. The 
V3-V4 region of 16S rDNA gene was amplified by PCR using Illumina adapter overhang nucleotide sequences 







Secretor positive % 
(Prevalence)
Male 37.15% (13/35) 40.43 ± 7.34 26.25 ± 3.50 61.54% (8/13)
Female 62.85% (22/35) 37.10 ± 9.95 21.77 ± 2.52 86.36% (19/22)
Total 100% (35/35) 38.43 ± 9.14 23.59 ± 3.68 77.14% (27/35)
Table 1.  Clinical characteristics of the volunteers.
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Nextera XT Index Kit. 1 μ l of the PCR product was checked with a Bioanalyzer DNA 1000 chip and libraries were 
sequenced using a 2 × 300pb paired-end run (MiSeq Reagent kit v3) on a MiSeq-Illumina platform (FISABIO 
sequencing service, Valencia, Spain). To rule out and control for possible reagent contamination, reagents for 
DNA extraction and for PCR amplification were also sequenced as controls.
Bioinformatics and Statistical analysis. Quality assessment was performed by the use of prinseq-lite 
program43 applying following parameters: min_length: 50; trim_qual_right: 20; trim_qual_type: mean; trim_
qual_window: 20. R1 and R2 from Illumina sequencing where joined using fastq-join from ea-tools suite44. Data 
were obtained using an ad-hoc pipeline written in RStatistics environment45 and data processing was performed 
using a QIIME pipeline (version 1.9.0)46. Chimeric sequences and sequences that could not be aligned were also 
removed from the data set. The clustered sequences were utilised to construct Operational Taxonomic Units 
(OTUs) tables with 97% identity and representative sequences were classified into the respective taxonomical 
level from phylum to genus based on the Greengenes 16S rRNA gene database. Sequences that could not be clas-
sified to domain level, or were classified as Cyanobacteria, were removed from the dataset as they likely represent 
ingested plant material. All communities were rarefied to 12,100 reads per sample to calculate bacterial diversity. 
Subsequently, alpha diversity indexes (Chao1 and Shannon) and beta diversity using UniFrac distance among 
samples and PERMANOVA47 was used to test significance. Calypso software version 5.2 (http://cgenome.net/
calypso/) was used with data transformed by square root with total sum normalization for the statistical analysis, 
multivariate test and data mining. To assess the relationship between FUT2 genotypes and the microbiota at 
family, genus and OTU levels the ANOVA test was utilized. Pearson’s correlations between the levels of bacte-
rial families and antibody levels were also calculated and plotted using Calypso software. Predictive functional 
analysis was performed using PICRUSt48 with Kyoto Encyclopedia of Genes and Genomes (KEGG) and linear 
discriminant analysis effect size (LEfSe)49 was used to detect unique biomarkers (LDA score > 3.0).
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